ÿþ<HTML><HEAD><TITLE>ImClone Systems, Inc. - Securities Class Action</TITLE> <META NAME='DESCRIPTION' CONTENT='<b>Summary:</b> On July 22, 2005, a plaintiffs notice of motion and motion for approval of settlements and fees was entered. Just as quickly, an Order and final judgment settling the action was entered on July 29, 2005. In addition, an Order in reply of attorney s fees was entered on August 03, 2005. Lastly, a motion for an order approving the administrative determinations of CGG accepting and rejecting claims was entered on May 08, 2007. Finally, an Order in regards to the distribution of class settlement fund was entered on May 30, 2007. According to the docket posted, on March 18, 2005, Judge Richard Owen signed an Order preliminarily approving the proposed settlement. A Settlement Hearing to determine, among other things, whether the proposed settlement is fair, reasonable and adequate was held on July 29, 2005 and Order and Final Judgment approving the Settlement was signed that same day. In a press release dated January 24, 2005, ImClone Systems Inc. agreed to pay $75 million to settle a 2002 class-action shareholder lawsuit accusing the company of making false or misleading statements about prospects for its Erbitux colon-cancer drug. ImClone will take a $55.4 million charge against its fourth-quarter earnings to cover the portion of the payment not covered by insurance. ImClone said all claims against the company and other named defendants in the class action will be dismissed with prejudice with no admission or finding of wrongdoing on the part of any defendant. Plaintiffs filed a Corrected Consolidated Amended Class Action Complaint (the  Consolidated Complaint ) on October 22, 2002, which Defendants opposed on November 25, 2002. Thereafter, on March 31, 2003, the Court consolidated all related cases and appointed Lead Plaintiffs and approved their selection of Lead Counsel. On June 4, 2003, the court issued an order granted in part and denied in part Defendants motions to dismiss. Defendants filed their Answers to the Consolidated Complaint on June 27, 2003. Plaintiffs filed a motion for class certification on December 22, 2003 and on April 15, 2004, the Court entered an Order certifying the action to proceed as a class action and defined the Class to consist of all persons or entities who purchased ImClone securities during the period between March 27, 2001 and January 25, 2002. The original Complaint alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, by issuing materially false and misleading statements to the market. Throughout the Class Period, defendants issued multiple press releases highlighting the successful progress of its "Fast-Track" application to the U.S. Food and Drug Administration ("FDA") for approval of IMC-C225, its blockbuster drug used for the treatment of colorectal cancer and also known as Erbitux, and the positive impact that the drug's approval would have on the Company's revenues. As alleged in the Complaint, these statements were materially false and misleading because, among other things, (i) defendants failed to comply with the FDA's requirements for filing the "Fast Track" application for approval of Erbitux; and (ii) as such, defendants knew, or should have known, that their deficient application would be rejected and would thus negatively impact the Company's future earnings. The Complaint further alleges that defendants filed their application, despite lacking the skill and expertise to make a proper filing, in order to convince Bristol-Myers Squibb Co. ("Bristol-Myers") to purchase at least $1 billion in ImClone stock, of which approximately $150 million was tendered by ImClone insiders, including the individual defendants, and to convince Bristol-Myers to make an additional $1 billion cash investment in the Company. On Friday evening, December 28, 2001, ImClone disclosed that the FDA had refused to accept the Company's deficient and defective application for approval of Erbitux, confirming almost two weeks of speculation that had already driven down the price of ImClone's stock by 21%, from a Class Period high of $73.83 per share on December 5, 2001 to $55.25 per share at the close of regular trading on December 28, 2001. Immediately following this shocking revelation, however, shares of ImClone dropped precipitously, falling $5.25 per share in after hours trading, or 9.5%, to close that session at $50 per share. On December 31, 2001, shares of ImClone continued to trade lower, and closed at $46.46 per share.'> <META NAME='KEYWORDS' CONTENT='ImClone Systems, Inc. - Securities Class Action, Class Action, Securities'></HEAD> <BODY background='/img/bg.gif' VLINK=#660000 ALINK=#DDDDDD LINK=#330066> <TABLE WIDTH=765> <TR><TD WIDTH=151><IMG SRC='/img/frond2.gif'></TD> <TD ALIGN='left'> <table width='600' border='0' cellspacing='0' cellpadding='0'> <tr> <td height='75'><img src='/img/scac_banner_600.jpg' width='600' height='85' usemap='#MapMapMap' border='0'><map name='MapMapMap'><area shape='rect' coords='338,56,591,77' href='http://www.cornerstone.com'><area shape='rect' coords='7,4,232,36' href='http://www.law.stanford.edu/'></map></td> </tr> <tr bgcolor='#330066'> <td height='35'> <table width='600' border='0' cellspacing='6' cellpadding='0' bgcolor='#330066' height='20'> <tr bgcolor='#330066'> <td height='20' width='297'><font face='Garmond,Helvetica,Times' size=4 color=#330066><b><font color='#FFFFFF'>Company and Case Information</font></b></font></td> <td height='20' width='285'> <div align='right'><b><font face='Garmond, Helvetica, Times' size='1' color='#660000'><font color='#FFFFFF'><font face='Garmond,Helvetica,Times'> </font></font><a href='##' onClick='window.open ('/warning/disclaimer.htm', 'avance', 'toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=no, resizable=no,valign=middle,align=center,width=480,h eight=465');'><font color='#FFFFFF'>IMPORTANT INFORMATION</font></a><font color='#FFFFFF'> | <a href='/search.shtml'><font color='#FFFFFF'></font></a></font><a href='/companies.html'><font color='#FFFFFF'>INDEX OF FILINGS</font></a><font color='#FFFFFF'> | <a href='/search.shtml'><font color='#FFFFFF'>SEARCH</font></a></font><font color='#FFFFFF'><a href='/search.shtml'></a></font><font color='#FFFFFF'><a href='/search.shtml'></a></font></font></b></div> </td> </tr> </table> </td> </tr> </table> </TD></TR> <TR><TD VALIGN='top'> <table width='136' border='0' cellspacing='7' cellpadding='0' height='558'> <tr valign='top' bgcolor='#330066'> <td height='770'> <p><font size='2' color='#000000'><font size='3' color='#FFFFFF'><a href='/index.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Home<br> <br> </font></a><a href='/companies.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Index of Filings</font></a><a href='/decisions.html'><font face='Garmond,Helvetica,Times'> </font></a><br> </font></font><br> <font size='3' color='#000000'><font color='#FFFFFF'><font size='3'><a href='/news.html'><font face='Garmond, Helvetica, Times' color='#FFFFFF'>News and Press Releases</font></a></font><br> </font></font><font size='3' color='#000000'><font color='#FFFFFF'><br> <a href='/filing.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Filings</font></a></font></font></p> <p><font size='3' color='#000000'><font color='#FFFFFF'><a href='/decisions.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Decisions</font></a></font></font></p> <p><font size='3' color='#000000'><font color='#FFFFFF'><a href='/research.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'></font></a></font><font size='3' color='#000000'><font color='#FFFFFF'><a href='/settle.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Settlements<br> </font></a></font></font></font></p> <p><font size='3' color='#000000'><font color='#FFFFFF'> </font></font><font size='3' color='#000000'><font color='#FFFFFF'><a href='/litigation_activity.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Litigation Activity Indices</font></a><br> </font></font></p> <p><font size='3' color='#000000'><font size='3' color='#000000'><font color='#FFFFFF'><a href='/top_ten_list.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Top Ten List</font></a></font></font></font></p> <p><font size='3' color='#000000'><font color='#FFFFFF'><a href='/annual_quarterly_updates.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Annual/Quarterly Updates</font></a> </font></font><font size='3'><br> <br> <font color='#000000'><font color='#FFFFFF'><a href='/clearinghouse_research.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Clearinghouse Research</font></a> </font></font><br> <a href='/news.html'><font face='Garmond, Helvetica, Times' color='#FFFFFF'><br> </font></a></font><font size='3' color='#000000'><font color='#FFFFFF'><a href='/research.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Articles & Papers</font><br> </a><a href='/lr.html'> <font face='Garmond,Helvetica,Times' color='#FFFFFF'> <br> </font></a><a href='/search.shtml'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Search</font></a> <br> <a href='/sites.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'><br> Related Sites</font></a><a href='/sponsor.html'><font face='Garmond,Helvetica,Times'><br> </font></a></font></font></p> <p><font size='3' color='#000000'><font color='#FFFFFF'><a href='/email.html'><font size='3' color='#000000'><font color='#FFFFFF'></font></font></a><font size='3' color='#000000'><font color='#FFFFFF'><a href='/lr.html'><font size='3' color='#000000'><font color='#FFFFFF'></font></font></a><font size='3' color='#000000'><font color='#FFFFFF'><a href='/email.html'><font size='3' color='#000000'><font color='#FFFFFF'></font></font></a><font size='3' color='#000000'><font color='#FFFFFF'><a href='/info.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>About Us<br> </font></a><a href='/search.shtml'><font face='Garmond,Helvetica,Times' color='#FFFFFF'></font></a></font></font><font face='Garmond,Helvetica,Times' color='#FFFFFF'></font></font></font><br> <a href='/lr.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Local Rules</font></a><br> <a href='/info.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'><br> </font></a></font></font><a href='/sponsor.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Sponsors</font></a></font><a href='/sponsor.html'><font face='Garmond,Helvetica,Times'><br> </font></a></font><br> <font size='3' color='#000000'><font color='#FFFFFF'><a href='/email.html'><font face='Garmond,Helvetica,Times' color='#FFFFFF'>Register</font></a></font></font></p> <p><font color='#000000'><img src='/img/nullbar.gif' width='120' height='8'></font><br> <font face='Garmond,Helvetica,Times' size='1' color='#FFFFFF'><b>_______________<br> </b></font><font face='Garmond,Helvetica,Times' size='1' color='#FFFFFF'><b>Copyright (c) 2001<br> Stanford Law School </b></font> </p> </td> </tr> </table> </TD><TD valign='top'><br><font FACE=Garmond,Helvetica,Times size=4 color=#330066><B> ImClone Systems, Inc.</B><font size=2> <form method='get' action='http://find.stanford.edu/search'> <input type='text' name='q' size='40' maxlength='255' value=''/> <font face='Garmond,Helvetica,Times' size=2 color=#330066><b><font size=1> <input type='submit' name='btnG' value='SEARCH CASE COURT FILINGS'/> </font></b></font> <input type='hidden' name='site' value='stanford'/> <input type='hidden' name='client' value='stanford'/> <input type='hidden' name='proxystylesheet' value='http://google.stanford.edu/stylesheet.xslt'/> <input type='hidden' name='output' value='xml_no_dtd'/> <input type='hidden' name='as_dt' value='i'/> <input type='hidden' name='as_sitesearch' value='http://securities.stanford.edu/1023/IMCL02-01'> </form> </font></font> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> <b>Conclusion:</b>&nbsp;On July 22, 2005, a plaintiffs notice of motion and motion for approval of settlements and fees was entered. Just as quickly, an Order and final judgment settling the action was entered on July 29, 2005. In addition, an Order in reply of attorney s fees was entered on August 03, 2005. Lastly, a motion for an order approving the administrative determinations of CGG accepting and rejecting claims was entered on May 08, 2007. Finally, an Order in regards to the distribution of class settlement fund was entered on May 30, 2007. <br><br> According to the docket posted, on March 18, 2005, Judge Richard Owen signed an Order preliminarily approving the proposed settlement. A Settlement Hearing to determine, among other things, whether the proposed settlement is fair, reasonable and adequate was held on July 29, 2005 and Order and Final Judgment approving the Settlement was signed that same day. <br><br> In a press release dated January 24, 2005, ImClone Systems Inc. agreed to pay $75 million to settle a 2002 class-action shareholder lawsuit accusing the company of making false or misleading statements about prospects for its Erbitux colon-cancer drug. ImClone will take a $55.4 million charge against its fourth-quarter earnings to cover the portion of the payment not covered by insurance. ImClone said all claims against the company and other named defendants in the class action will be dismissed with prejudice with no admission or finding of wrongdoing on the part of any defendant. <br><br> Plaintiffs filed a Corrected Consolidated Amended Class Action Complaint (the  Consolidated Complaint ) on October 22, 2002, which Defendants opposed on November 25, 2002. Thereafter, on March 31, 2003, the Court consolidated all related cases and appointed Lead Plaintiffs and approved their selection of Lead Counsel. On June 4, 2003, the court issued an order granted in part and denied in part Defendants motions to dismiss. Defendants filed their Answers to the Consolidated Complaint on June 27, 2003. Plaintiffs filed a motion for class certification on December 22, 2003 and on April 15, 2004, the Court entered an Order certifying the action to proceed as a class action and defined the Class to consist of all persons or entities who purchased ImClone securities during the period between March 27, 2001 and January 25, 2002. <br><br> The original Complaint alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, by issuing materially false and misleading statements to the market. Throughout the Class Period, defendants issued multiple press releases highlighting the successful progress of its "Fast-Track" application to the U.S. Food and Drug Administration ("FDA") for approval of IMC-C225, its blockbuster drug used for the treatment of colorectal cancer and also known as Erbitux, and the positive impact that the drug's approval would have on the Company's revenues. As alleged in the Complaint, these statements were materially false and misleading because, among other things, (i) defendants failed to comply with the FDA's requirements for filing the "Fast Track" application for approval of Erbitux; and (ii) as such, defendants knew, or should have known, that their deficient application would be rejected and would thus negatively impact the Company's future earnings. The Complaint further alleges that defendants filed their application, despite lacking the skill and expertise to make a proper filing, in order to convince Bristol-Myers Squibb Co. ("Bristol-Myers") to purchase at least $1 billion in ImClone stock, of which approximately $150 million was tendered by ImClone insiders, including the individual defendants, and to convince Bristol-Myers to make an additional $1 billion cash investment in the Company. On Friday evening, December 28, 2001, ImClone disclosed that the FDA had refused to accept the Company's deficient and defective application for approval of Erbitux, confirming almost two weeks of speculation that had already driven down the price of ImClone's stock by 21%, from a Class Period high of $73.83 per share on December 5, 2001 to $55.25 per share at the close of regular trading on December 28, 2001. Immediately following this shocking revelation, however, shares of ImClone dropped precipitously, falling $5.25 per share in after hours trading, or 9.5%, to close that session at $50 per share. On December 31, 2001, shares of ImClone continued to trade lower, and closed at $46.46 per share.<br> <HR WIDTH=50% ALIGN=left> INDUSTRY CLASSIFICATION:<br> <b>SIC Code:</b> 2836<br> <b>Sector:</b> Healthcare<br> <b>Industry:</b> Biotechnology & Drugs<br> </font><p></P><HR> <TABLE width='100%'> <TR> <TD ALIGN='left' width='30%'><font FACE=Garmond,Helvetica,Times size=1 color=#330066><B> COMPANY/ISSUER NAME:</B></font></TD> <TD ALIGN='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066><B> ImClone Systems, Inc.</B></font></TD> </TR> <TR> <TD ALIGN='left' width='30%'><font FACE=Garmond,Helvetica,Times size=1 color=#330066><B> COMPANY/ISSUER TICKER:</B></font></TD> <TD ALIGN='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066><B> IMCL</B></font></TD> </TR> <TR> <TD ALIGN='left' width='30%'><font FACE=Garmond,Helvetica,Times size=1 color=#330066><B> COMPANY WEBSITE:</B></font></TD> <TD ALIGN='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066><B> <A HREF='http://www.imclone.com'>http://www.imclone.com</A></B></font></TD> </TR> </TABLE><HR> <TABLE BORDER=0 width=100%> <TR><TD COLSPAN = 4><B><font FACE=Garmond,Helvetica,Times size=2 color=#330066> FIRST IDENTIFIED COMPLAINT IN THE DATABASE</font></B></TD></TR> <TR><TD colspan=4 align='left' bgcolor='#330066'> <font FACE=Garmond,Helvetica,Times size=2 color=#FFFFFF><B>Irvine, et al. v. ImClone Systems, Inc., et al.</B></font></TD></TR> <TR><TD align='left' colspan='4'><div align='left'> <table width='100%' CELLPADDING='0' CELLSPACING='0' BORDER='1'> <TR><TD align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;COURT:&nbsp;<b>S.D. New York</b></font></TD> <TD ALIGN='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;DOCKET NUMBER:&nbsp;<b>02-CV-00109</b><font></font></font></TD></TR> <TR><TD align='left' colspan=2 bgcolor='#DDDDDD'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;JUDGE NAME:&nbsp;<b>Hon. Richard Owen </b></font></TD></TR> <TR><TD align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;DATE FILED:&nbsp;<b>01/07/2002</b></font></TD> <TD align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;SOURCE:&nbsp;<b>Business Wires<b></b></b></font></TD></TR> <TR><TD align='left' bgcolor='#DDDDDD'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;CLASS PERIOD START:&nbsp;<b>05/12/2001<b></b></b></font></td> <TD align='left' bgcolor='#DDDDDD'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;CLASS PERIOD END:&nbsp;<b>01/04/2002</b></font></TD></TR> <TR><TD align='left' colspan=2><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;TYPE OF COMPLAINT:&nbsp;<b>Complaint (Unamended and Unconsolidated)</b></font></TD></TR> <TR><TD align='left' colspan=2 bgcolor='#DDDDDD'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;PLAINTIFF FIRMS NAMED IN COMPLAINT:</font></TD></TR> <TR><TD align='left' colspan=2><font FACE=Garmond,Helvetica,Times size=2 color=#330066><LI> <A HREF=''>Beatie & Osborne LLP</A><BR>&nbsp;&nbsp;599 Lexington Avenue, 42nd Floor, New York, NY, 10022<BR> &nbsp;&nbsp; (voice) 212.888.9000, (fax) 212.888.9664, <LI> <A HREF='http://www.bergermontague.com/'>Berger & Montague PC</A><BR>&nbsp;&nbsp;1622 Locust Street, Philadelphia, PA, 19103<BR> &nbsp;&nbsp; (voice) 800.424.6690, (fax) 215.875.4604, investorprotect@bm.net <LI> <A HREF='http://www.bermanesq.com'>Berman DeValerio Pease Tabacco Burt & Pucillo (MA)</A><BR>&nbsp;&nbsp;One Liberty Square, Boston, MA, 2109<BR> &nbsp;&nbsp; (voice) 617.542.8300, (fax) 617.230.0903, info@bermanesq.com <LI> <A HREF='http://www.bernardmgross.com/'>Bernard M. Gross</A><BR>&nbsp;&nbsp;1500 Walnut Street, Suite 600, Philadelphia, PA, 19102<BR> &nbsp;&nbsp; (voice) 215.561.3600, (fax) 215.561.3000, bmgross@BernardMGross.com <LI> <A HREF='http://www.bernlieb.com/'>Bernstein Liebhard & Lifshitz LLP (New York, NY)</A><BR>&nbsp;&nbsp;10 E. 40th Street, 22nd Floor, New York, NY, 10016<BR> &nbsp;&nbsp; (voice) 800.217.1522, (fax) , info@bernlieb.com <LI> <A HREF=''>Brian Felgoise</A><BR>&nbsp;&nbsp;230 South Broad Street, Suite 404 , Philadelphia, PA, 19102 <BR> &nbsp;&nbsp; (voice) 215.735.6810, (fax) 215/735.5185., <LI> <A HREF='http://www.brodsky-smith.com '>Brodsky & Smith, LLC (former Pennysylvania)</A><BR>&nbsp;&nbsp;11 Bala Avenue, Suite 39, Bala Cynwyd, PA, 19004<BR> &nbsp;&nbsp; (voice) 610.668.7987, (fax) 610.660.0450, esmith@Brodsky-Smith.com <LI> <A HREF='http://www.nyclasslaw.com/'>Bull & Lifshitz</A><BR>&nbsp;&nbsp;18 East 41st St., New York, NY, 10017<BR> &nbsp;&nbsp; (voice) 212.213.6222, (fax) 212.213.9405, <LI> <A HREF='http://www.cauleygeller.com'>Cauley Geller Bowman Coates & Rudman LLP (Little Rock, AR)</A><BR>&nbsp;&nbsp;P.O. Box 25438, Little Rock, AR, 72221-5438<BR> &nbsp;&nbsp; (voice) 501.312.8500, (fax) 501.312.8505, <LI> <A HREF='http://www.cmht.com'>Cohen Milstein Hausfeld & Toll PLLC (Seattle WA)</A><BR>&nbsp;&nbsp;701 Fifth Avenue, Suite 6860, Seattle, WA, 98014<BR> &nbsp;&nbsp; (voice) 206.521.0080, (fax) 206.521.0166, lawinfo@cmht.com <LI> <A HREF='http://www.glrs.com/'>Goodkind Labaton Rudoff & Sucharow LLP</A><BR>&nbsp;&nbsp;100 Park Avenue, New York, NY, 10017<BR> &nbsp;&nbsp; (voice) 212.907.0700, (fax) 212.818.0477, info@glrslaw.com <LI> <A HREF='http://www.holzerlaw.com/'>Holzer & Holzer, LLC</A><BR>&nbsp;&nbsp;1117 Perimeter Center West, Suite E-107, Atlanta, GA, 30338<BR> &nbsp;&nbsp; (voice) (770) 392-0090, (fax) (770) 392-0029, mfistel@holzerlaw.com <LI> <A HREF=''>James V. Bashian</A><BR>&nbsp;&nbsp;500 Fifth Ave Ste 2800, New York, NY, 10110<BR> &nbsp;&nbsp; (voice) , (fax) , <LI> <A HREF='http://www.kaplanfox.com'>Kaplan Fox & Kilsheimer, LLP (former New York, NY)</A><BR>&nbsp;&nbsp;805 Third Avenue, 22nd Floor, New York, NY, 10022<BR> &nbsp;&nbsp; (voice) 212.687.1980, (fax) 212.687.7714, info@kaplanfox.com <LI> <A HREF='http://www.kmslaw.com '>Kirby McInerney & Squire LLP</A><BR>&nbsp;&nbsp;830 Third Avenue 10th Floor, New York Ave, NY, 10022<BR> &nbsp;&nbsp; (voice) 212.317.2300, (fax) , <LI> <A HREF='http://www.nasd-law.com/ '>Klayman & Toskes, P.A. </A><BR>&nbsp;&nbsp;11 Broadway, Suite 400, New York, NY, 10004<BR> &nbsp;&nbsp; (voice) 888/997-9956, (fax) 561/361-9178, stoskes@nasd-law.com <LI> <A HREF=''>Law Offices of Charles J. Piven, P.A.</A><BR>&nbsp;&nbsp;World Trade Center-Baltimore,401 East Pratt Suite 2525, Baltimore, MD, 21202<BR> &nbsp;&nbsp; (voice) 410.332.0030, (fax) , pivenlaw@erols.com <LI> <A HREF='http://members.aol.com/mhenzel182/frame.htm'>Law Offices of Marc S. Henzel (Lawrence)</A><BR>&nbsp;&nbsp;335 Central Avenue, Lawrence, NY, 11559<BR> &nbsp;&nbsp; (voice) 516.374.0707, (fax) 516.295.3473, securitiesfraud@comcast.net <LI> <A HREF='http://www.SecuritiesAttorney.com'>Leo W. Desmond</A><BR>&nbsp;&nbsp;2161 Palm Beach Lakes Boulevard, Suite 204, West Palm Beach, FL, 33409<BR> &nbsp;&nbsp; (voice) 561.712.8000, (fax) 561.712.8000, stocklaw@bellsouth.net <stocklaw@bellsouth.net> <LI> <A HREF=''>Levy & Levy</A><BR>&nbsp;&nbsp;, , , <BR> &nbsp;&nbsp; (voice) , (fax) , <LI> <A HREF='http://www.ldbs.com/'>Lowey, Dannenberg, Bemporad & Selinger, P.C.</A><BR>&nbsp;&nbsp;1 North Lexington Avenue, 11th Floor, White Plains, NY, 10601-1714<BR> &nbsp;&nbsp; (voice) 914.997.0500, (fax) 914.997.0035, ldbs@wesetnet.com <LI> <A HREF='http://www.milberg.com'>Milberg Weiss Bershad Hynes & Lerach LLP (New York, NY)</A><BR>&nbsp;&nbsp;One Pennsylvania Plaza, New York, NY, 10119-1065<BR> &nbsp;&nbsp; (voice) 212.594.5300, (fax) , <LI> <A HREF='http://www.pomerantzlaw.com'>Pomerantz Haudek Block Grossman & Gross LLP (New York)</A><BR>&nbsp;&nbsp;100 Park Avenue, 26th Floor, New York, NY, 10017-5516ven<BR> &nbsp;&nbsp; (voice) 212.661.1100, (fax) 212.661.8665, info@pomerantzlaw.com/ <LI> <A HREF='http://www.murrayfrank.com/'>Rabin & Peckel LLP</A><BR>&nbsp;&nbsp;275 Madison Avenue, 34th Floor, New York, NY, 10016<BR> &nbsp;&nbsp; (voice) 212.682.1818, (fax) 212.682.1892, email@rabinlaw.com <LI> <A HREF='http://www.snlaw.net/'>Schatz & Nobel, P.C.</A><BR>&nbsp;&nbsp;330 Main Street, Hartford, CT, 06106<BR> &nbsp;&nbsp; (voice) 800.797.5499, (fax) 860.493.6290, sn06106@AOL.com <LI> <A HREF='http://www.sbclasslaw.com'>Schiffrin & Barroway LLP</A><BR>&nbsp;&nbsp;3 Bala Plaza E, Bala Cynwyd, PA, 19004<BR> &nbsp;&nbsp; (voice) 610.667.7706, (fax) 610.667.7056, info@sbclasslaw.com <LI> <A HREF='http://www.scott-scott.com/'>Scott & Scott LLC (Connecticut)</A><BR>&nbsp;&nbsp;P.O. Box 192, 108 Norwich Avenue, Colchester, CT, 06415<BR> &nbsp;&nbsp; (voice) 860.537.5537, (fax) 860.537.4432, scottlaw@scott-scott.com <LI> <A HREF='http://www.shulaw.com/'>Shapiro Haber & Urmy LLP (Boston)</A><BR>&nbsp;&nbsp;75 State Street, Boston, MA, 02109<BR> &nbsp;&nbsp; (voice) 617.439.3939, (fax) 617.439.0134, info@shulaw.com <LI> <A HREF='http://www.srk-law.com'>Spector Roseman & Kodroff (San Diego)</A><BR>&nbsp;&nbsp;1818 Market Street, Suite 2500, Philadelphia, PA, 19103<BR> &nbsp;&nbsp; (voice) 215.496.0300, (fax) 215.496.6611, <LI> <A HREF='http//www.ssbny.com'>Stull, Stull & Brody (New York)</A><BR>&nbsp;&nbsp;6 East 45th Street, New York, NY, 10017<BR> &nbsp;&nbsp; (voice) 310.209.2468, (fax) 310.209.2087, SSBNY@aol.com <LI> <A HREF='http://www.whesq.com'>Wechsler Harwood LLP</A><BR>&nbsp;&nbsp;488 Madison Avenue 8th Floor, New York, NY, 10022<BR> &nbsp;&nbsp; (voice) 212.935.7400, (fax) , info@whhf.com <LI> <A HREF='http://www.wyca.com'>Weiss & Yourman (New York, NY)</A><BR>&nbsp;&nbsp;The French Building, 551 Fifth Ave., Suite 1600, New York, NY, 10126<BR> &nbsp;&nbsp; (voice) 212.682.3025, (fax) 212.682.3010, info@wyca.com <LI> <A HREF='http://www.whafh.com/'>Wolf Haldenstein Adler Freeman & Herz LLP (New York)</A><BR>&nbsp;&nbsp;270 Madison Avenue, New York, NY, 10016<BR> &nbsp;&nbsp; (voice) 212.545.4600, (fax) 212.686.0114, newyork@whafh.com <LI> <A HREF='http://www.wolfpopper.com'>Wolf Popper, LLP</A><BR>&nbsp;&nbsp;845 Third Avenue, New York, NY, 10022-6689Ave<BR> &nbsp;&nbsp; (voice) 877.370.7703, (fax) 212.486.2093, IRRep@wolfpopper.com <BR> <font face='Garmond,Helvetica,Times' size=1 color='#330066'> _____________________________________________ </font><BR> &nbsp;TOTAL NUMBER OF PLAINTIFF FIRMS:&nbsp; <b>34</b></font></TD></tr> </table></div> </TD></TR> </TABLE> <BR> <TABLE CELLPADDING=0 CELLSPACING=0 BORDER=1 width=100%> <TR><TD COLSPAN=4 bgcolor=#330066><font FACE=Garmond,Helvetica,Times size=2 color=#FFFFFF> &nbsp;DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT</font></TD></TR><TR> <TD COLSPAN=4 bgcolor=#DDDDDD><font FACE=Garmond,Helvetica,Times size=2 color=#330066><b><A HREF='/1023/IMCL02-01/200217_f01c_0200109.pdf'>Class Action Complaint</A></b></font> </TD> </TR> <TR> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Type:&nbsp;Complaint</font> </TD> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Date on the document:&nbsp;01/07/2002</font> </TD> </TR></TABLE><TABLE BORDER=0 width=100%> <TR><TD COLSPAN = 4> <font FACE=Garmond,Helvetica,Times size=2 color=#330066><b> <HR>REFERENCE COMPLAINT</b></font></TD></TR> <TR><TD colspan=4 align='left' bgcolor='#330066'> <font FACE=Garmond,Helvetica,Times size=2 color=#FFFFFF> <b>In Re: ImClone Systems, Inc. Securities Litigation</b></font></TD></TR> <TR><TD align='left' colspan='4'><div align='left'> <table width='100%' CELLPADDING='0' CELLSPACING='0' BORDER='1'> <TR><TD align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;COURT:&nbsp;<b>S.D. New York</b></font></TD> <TD align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;DOCKET NUMBER:&nbsp;<b>02-CV-00109</b></font></TD></TR> <TR><TD align='left' colspan=2 bgcolor='#DDDDDD'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;JUDGE NAME:&nbsp;<b>Hon. Richard Owen</b></font></TD></TR> <TR><TD align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;DATE FILED:&nbsp<b>10/22/2002</b></font></TD> <TD align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;SOURCE:&nbsp;<b>Business Wires</b></font></TD></TR> <TR><TD align='left' bgcolor='#DDDDDD'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;CLASS PERIOD START:&nbsp;<b>03/27/2001</b></font></TD> <TD align='left' bgcolor='#DDDDDD'><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;CLASS PERIOD END:&nbsp;<b>01/25/2002</b></font></TD></TR> <TR><TD align='left' colspan=2><font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;TYPE OF COMPLAINT:&nbsp;<b>Consolidated Complaint</b></font></TD></TR> <TR><TD align='left' colspan=2 bgcolor='#DDDDDD'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> &nbsp;PLAINTIFF FIRMS NAMED IN COMPLAINT:</font></TD></TR> <TR><TD align='left' colspan=2><font FACE=Garmond,Helvetica,Times size=2 color=#330066><LI> <A HREF='http://www.milbergweiss.com '>Milberg Weiss Bershad & Schulman LLP (New York)</A><BR>&nbsp;&nbsp;One Pennsylvania Plaza, 49th Floor, New York, NY, 10119<BR> &nbsp;&nbsp; (voice) 212.594.5300, (fax) 212.868.1229, info@milbergweiss.com <LI> <A HREF='http://www.scott-scott.com/'>Scott & Scott LLC (Connecticut)</A><BR>&nbsp;&nbsp;P.O. Box 192, 108 Norwich Avenue, Colchester, CT, 06415<BR> &nbsp;&nbsp; (voice) 860.537.5537, (fax) 860.537.4432, scottlaw@scott-scott.com <BR> <font face='Garmond,Helvetica,Times' size=1 color='#330066'> _____________________________________________ </font><BR> &nbsp;TOTAL NUMBER OF PLAINTIFF FIRMS:&nbsp; <b>2</b></font></TD></TR> </table></div> </TABLE><BR> <TABLE CELLPADDING=0 CELLSPACING=0 BORDER=1 width=100%> <TR><TD COLSPAN=4 bgcolor=#330066><font FACE=Garmond,Helvetica,Times size=2 color=#FFFFFF> &nbsp;DOCUMENTS FOR THE REFERENCE COMPLAINT</font></TD></TR><TR> <TD COLSPAN=4 bgcolor=#DDDDDD><font FACE=Garmond,Helvetica,Times size=2 color=#330066><b><A HREF='/1023/IMCL02-01/200541_r01n_0200109.pdf'>Notice Of Pendency Of Class Action And Proposed Settlement, Motion For Attorneys Fees And Settlement Hearing</A></b></font> </TD> </TR> <TR> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Type:&nbsp;Notice</font> </TD> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Date on the document:&nbsp;04/01/2005</font> </TD> </TR><TR> <TD COLSPAN=4 bgcolor=#DDDDDD><font FACE=Garmond,Helvetica,Times size=2 color=#330066><b><A HREF='/1023/IMCL02-01/200541_r02x_0200109.pdf'>Proof of Claim and Release</A></b></font> </TD> </TR> <TR> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Type:&nbsp;Other</font> </TD> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Date on the document:&nbsp;04/01/2005</font> </TD> </TR><TR> <TD COLSPAN=4 bgcolor=#DDDDDD><font FACE=Garmond,Helvetica,Times size=2 color=#330066><b><A HREF='/1023/IMCL02-01/200569_r02x_0200109.pdf'>Addendum To Proof Of Claim And Release</A></b></font> </TD> </TR> <TR> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Type:&nbsp;Other</font> </TD> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Date on the document:&nbsp;06/09/2005</font> </TD> </TR><TR> <TD COLSPAN=4 bgcolor=#DDDDDD><font FACE=Garmond,Helvetica,Times size=2 color=#330066><b><A HREF='/1023/IMCL02-01/200569_r01n_0200109.pdf'>Supplemental Notice To Persons Who Purchased Imclone Systems Incorporated ( ImClone ) 5 1/2% Convertible Notes Due 3/1/2004 (Cusip Number 45245wad1) (The  Convertible Notes ) On The Open Market During The Period Between And Including March 27, 2001 And January 25, 2002 (The  Class Period )</A></b></font> </TD> </TR> <TR> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Type:&nbsp;Notice</font> </TD> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Date on the document:&nbsp;06/09/2005</font> </TD> </TR><TR> <TD COLSPAN=4 bgcolor=#DDDDDD><font FACE=Garmond,Helvetica,Times size=2 color=#330066><b><A HREF='/1023/IMCL02-01/2007530_r01k_0200109.pdf'>US District Court Civil Docket</A></b></font> </TD> </TR> <TR> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Type:&nbsp;Docket</font> </TD> <TD COLSPAN=2 align='left'><font FACE=Garmond,Helvetica,Times size=2 color=#330066>Date on the document:&nbsp;5/30/2007</font> </TD> </TR></TABLE><BR> <TABLE CELLPADDING=0 CELLSPACING=0 BORDER=1 width=100%><TR><TD COLSPAN=4 bgcolor=#330066><font FACE=Garmond,Helvetica,Times size=2 color=#FFFFFF> &nbsp;OTHER DOCUMENTS</font></TD></TR><TR><TD COLSPAN=4 bgcolor=#DDDDDD> <font FACE=Garmond,Helvetica,Times size=2 color=#330066><b> <A HREF='/1023/IMCL02-01/20020108_f01c_Krosser.pdf'>Class Action Complaint For Violations Of Federal Securities Laws</A></b></font></TD></TR> <TR><TD COLSPAN=4 align='left'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> Case Name and/or Number:&nbsp;Krosser, et al. v. ImClone Systems, Inc., et al.</font> </TD></TR> <TR> <TD COLSPAN=2 align='left'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> Type:&nbsp;Complaint</font></TD> <TD COLSPAN=2 align='left'> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> Date on the document:&nbsp;01/08/2002</font></TD> </TR></TABLE> <font FACE=Garmond,Helvetica,Times size=2 color=#330066> <HR><b>WARNING AND DISCLAIMER OF LIABILITY:</b><br> The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful. <HR> </font> <font FACE=Garmond,Helvetica,Times size=1 color=#330066> Go to <A HREF='/search.shtml'> <font FACE=Garmond,Helvetica,Times size=1 color=#330066>Search</font></A> &nbsp;page |</font> <font FACE=Garmond,Helvetica,Times size=1 color=#330066> Go to <A HREF='/companies.html'> <font FACE=Garmond,Helvetica,Times size=1 color=#330066>Case Index</font></A> &nbsp;page |</font> <font FACE=Garmond,Helvetica,Times size=1 color=#330066> Back to <A HREF=#top><font FACE=Garmond,Helvetica,Times size=1 color=#330066> Top</font></A><BR><BR></font><BR> </TD></TR></TABLE></BODY></HTML>